Integrating graph attention networks and deep learning with multi-stage computational screening: Bisdemethoxycurcumin as a potent A₂A receptor inhibitor for Parkinson's disease.

Otmanine K, Hammoudi M, Bendriss H, Feraoun B, Mekhane S, Gherioune N, Benmehache C, Kerrouzi I, Ayadi K, El Miloudi K, Benghalia MA, Otmanine MK, Hentabli M

Open source

DOI
10.1016/j.bioorg.2026.110653
Published
2026 Oct 14
Container
Bioorganic chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bioorg.2026.110653,
  title = {Integrating graph attention networks and deep learning with multi-stage computational screening: Bisdemethoxycurcumin as a potent A₂A receptor inhibitor for Parkinson's disease.},
  author = {Otmanine K and Hammoudi M and Bendriss H and Feraoun B and Mekhane S and Gherioune N and Benmehache C and Kerrouzi I and Ayadi K and El Miloudi K and Benghalia MA and Otmanine MK and Hentabli M},
  year = {2026},
  journal = {Bioorganic chemistry},
  doi = {10.1016/j.bioorg.2026.110653},
  url = {https://doi.org/10.1016/j.bioorg.2026.110653}
}

RIS

TY  - JOUR
TI  - Integrating graph attention networks and deep learning with multi-stage computational screening: Bisdemethoxycurcumin as a potent A₂A receptor inhibitor for Parkinson's disease.
AU  - Otmanine K
AU  - Hammoudi M
AU  - Bendriss H
AU  - Feraoun B
AU  - Mekhane S
AU  - Gherioune N
AU  - Benmehache C
AU  - Kerrouzi I
AU  - Ayadi K
AU  - El Miloudi K
AU  - Benghalia MA
AU  - Otmanine MK
AU  - Hentabli M
PY  - 2026
JO  - Bioorganic chemistry
DO  - 10.1016/j.bioorg.2026.110653
UR  - https://doi.org/10.1016/j.bioorg.2026.110653
ER  - 

APA

K, O., M, H., H, B., B, F., S, M., N, G., C, B., I, K., K, A., K, E. M., MA, B., MK, O., & M, H. (2026). Integrating graph attention networks and deep learning with multi-stage computational screening: Bisdemethoxycurcumin as a potent A₂A receptor inhibitor for Parkinson's disease.. Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2026.110653

Source records